These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 16650772)

  • 41. Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion.
    Abbink F; Buisman AM; Doornbos G; Woldman J; Kimman TG; Conyn-van Spaendonck MA
    J Infect Dis; 2005 Mar; 191(6):990-9. PubMed ID: 15717277
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Laboratory surveillance for wild and vaccine-derived polioviruses--worldwide, January 2006-June 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(37):965-9. PubMed ID: 17882127
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Public health. Is polio eradication realistic?
    Arita I; Nakane M; Fenner F
    Science; 2006 May; 312(5775):852-4. PubMed ID: 16690846
    [No Abstract]   [Full Text] [Related]  

  • 44. Progress toward poliomyelitis eradication--Nigeria, 2005-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(12):278-81. PubMed ID: 17392680
    [TBL] [Abstract][Full Text] [Related]  

  • 45. OPV cannot eradicate polio from India: do we need any further evidence?
    Paul Y
    Vaccine; 2008 Apr; 26(17):2058-61. PubMed ID: 18378367
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Shedding of sabin poliovirus Type 3 containing the nucleotide 472 uracil-to-cytosine point mutation after administration of oral poliovirus vaccine.
    Martinez CV; Old MO; Kwock DK; Khan SS; Garcia JJ; Chan CS; Webster R; Falkovitz-Halpern MS; Maldonado YA
    J Infect Dis; 2004 Jul; 190(2):409-16. PubMed ID: 15216480
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of vaccine-derived polioviruses in sewage and river water in South Africa.
    Pavlov DN; Van Zyl WB; Van Heerden J; Grabow WO; Ehlers MM
    Water Res; 2005 Sep; 39(14):3309-19. PubMed ID: 15996707
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Twenty-Eight Years of Poliovirus Replication in an Immunodeficient Individual: Impact on the Global Polio Eradication Initiative.
    Dunn G; Klapsa D; Wilton T; Stone L; Minor PD; Martin J
    PLoS Pathog; 2015 Aug; 11(8):e1005114. PubMed ID: 26313548
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evolution of poliovirus type I during 5.5 years of prolonged enteral replication in an immunodeficient patient.
    Bellmunt A; May G; Zell R; Pring-Akerblom P; Verhagen W; Heim A
    Virology; 1999 Dec; 265(2):178-84. PubMed ID: 10600590
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of CHAT and Cox type 1 live-attenuated poliovirus vaccine strains.
    Martín J; Minor PD
    J Virol; 2002 Jun; 76(11):5339-49. PubMed ID: 11991962
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Live-attenuated strains of improved genetic stability.
    Macadam AJ; Ferguson G; Stone DM; Meredith J; Almond JW; Minor PD
    Dev Biol (Basel); 2001; 105():179-87. PubMed ID: 11763326
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Progress toward poliomyelitis eradication--India, January 2005-June 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Jul; 55(28):772-6. PubMed ID: 16855526
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A case for developing antiviral drugs against polio.
    Collett MS; Neyts J; Modlin JF
    Antiviral Res; 2008 Sep; 79(3):179-87. PubMed ID: 18513807
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Portugal and Europe are poliomyelitis free].
    Gonçalves G; Santos LA; Sarmento A; Rocha G; Valente P
    Acta Med Port; 2003; 16(1):33-9. PubMed ID: 12828004
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reversion of neurovirulent mutations, recombination and high intra-host diversity in vaccine-derived poliovirus excreted by patients with primary immune deficiency.
    Ben Salem I; Khemiri H; Drechsel O; Arbi M; Böttcher S; Mekki N; Ben Fraj I; Souiai O; Yahyaoui M; Ben Farhat E; Meddeb Z; Touzi H; Ben Mustapha I; BenKahla A; Ouederni M; Barbouche MR; Diedrich S; Triki H; Haddad-Boubaker S
    J Med Virol; 2024 Sep; 96(9):e29918. PubMed ID: 39311394
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Poliovirus vaccine shedding among persons with HIV in Abidjan, Cote d'Ivoire.
    Hennessey KA; Lago H; Diomande F; Akoua-Koffi C; Caceres VM; Pallansch MA; Kew OM; Nolan M; Zuber PL
    J Infect Dis; 2005 Dec; 192(12):2124-8. PubMed ID: 16288377
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk management in a polio-free world.
    Bruce Aylward R; Sutter RW; Cochi SL; Thompson KM; Jafari H; Heymann D
    Risk Anal; 2006 Dec; 26(6):1441-8. PubMed ID: 17184391
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Circulating vaccine derived polio viruses and their impact on global polio eradication.
    Wagner BG; Earn DJ
    Bull Math Biol; 2008 Jan; 70(1):253-80. PubMed ID: 17934778
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Progress toward interruption of wild poliovirus transmission--worldwide, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Apr; 58(12):308-12. PubMed ID: 19343011
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A vision of a world without polio: the OPV cessation strategy.
    Heymann DL; Sutter RW; Aylward RB
    Biologicals; 2006 Jun; 34(2):75-9. PubMed ID: 16682224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.